Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
23.39
+0.32 (1.39%)
At close: Jul 25, 2025, 4:00 PM
22.62
-0.77 (-3.29%)
After-hours: Jul 25, 2025, 7:50 PM EDT
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $334.10 million as of July 25, 2025. Its market cap has increased by 77.27% in one year.
Market Cap
334.10M
Enterprise Value
224.11M
1-Year Change
77.27%
Ranking
Category
Stock Price
$23.39
Market Cap Chart
Since the IPO on May 29, 2024, Inhibrx Biosciences's market cap has increased from $198.24M to $334.10M, an increase of 68.54%. That is a compound annual growth rate of 57.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2025 | 333.96M | 49.81% |
| Dec 31, 2024 | 222.93M | 12.46% |
| May 29, 2024 | 198.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 697.04B |
| Johnson & Johnson | 404.05B |
| AbbVie | 330.51B |
| Novo Nordisk | 295.77B |
| UnitedHealth Group | 258.65B |
| Novartis AG | 224.80B |
| Abbott Laboratories | 218.75B |
| AstraZeneca | 216.82B |